{"name":"Peng Yuan","slug":"peng-yuan","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Endostar","genericName":"Endostar","slug":"endostar","indication":"Other","status":"marketed"},{"name":"Observation arm","genericName":"Observation arm","slug":"observation-arm","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Endostar","genericName":"Endostar","slug":"endostar","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Observation arm","genericName":"Observation arm","slug":"observation-arm","phase":"marketed","mechanism":"An observation arm is a non-interventional study group used to monitor natural disease progression or outcomes without active drug treatment.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE81dl9HTFJLdEpoY2dHdGlXVUMtUlV4SjROel9qZ1U1Z25OZUVGTVg2bVc1MDl0VXFieDA4TkhZSmJCSGJ0V2FodkR6MEEwVUVoMGd4QzhhTWVrajNEM05Z?oc=5","date":"2025-01-17","type":"pipeline","source":"Nature","summary":"Integrative genetics and multiomics analysis reveal mechanisms and therapeutic targets in vitiligo highlighting JAK STAT pathway regulation of CTSS - Nature","headline":"Integrative genetics and multiomics analysis reveal mechanisms and therapeutic targets in vitiligo highlighting JAK STAT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQZ3Vpemw0bXJjeTQxM3piZ29wZjg0Z1ZRMUxRNzdWcmpNU3I3Slh4cUs0NjFiSmV2T3NoU1ZEVExHLUp4M0Q1OTRhVFJqb2NiX2EwS3UzMWdNX0Y3QnBIZXVCTGVTTUsxcTZHNkhYUHB6SWVTTVhldEhqcFlfMzgyeTZHNzROYlVsTTFSTmpyd2t0UQ?oc=5","date":"2020-06-02","type":"pipeline","source":"Frontiers","summary":"Characterization of the Rifamycin-Degrading Monooxygenase From Rifamycin Producers Implicating Its Involvement in Saliniketal Biosynthesis - Frontiers","headline":"Characterization of the Rifamycin-Degrading Monooxygenase From Rifamycin Producers Implicating Its Involvement in Salini","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}